CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Source: insidermonkey.com
Sure Lung News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sure Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sure Lung Today - Breaking & Trending Today
CareDx Shares Rise 10% After AlloSure Lung Testing Service Receives Medicare Coverage
By Chris Wack CareDx shares were up 10% at $10.69 after the company said its AlloSure Lung donor-derived cell-free DNA molecular testing service has received...
Source: marketwatch.com
CareDx's AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
AlloSure Lung Represents First dd-cfDNA Approved by Medicare for Lung Transplant Patients
Source: marketscreener.com
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
Record Number of 65 Abstracts Showcasing CareDx Innovation Including Data Showing Clinical Utility of AlloSure Kidney to Guide Immunosuppression Management Experts Review Advancements in... | June 1, 2023
Source: marketscreener.com
AlloSure, the First dd-cfDNA in Heart and Kidney
AlloSure Significantly Improves Management of High-Risk Lung Transplant Patients...
Source: globenewswire.com